Analysing a prospective cohort of blood samples from lung cancer patients across different stages, we uncovered that CXCL14 in plasma predicted the occurrence of metastasis and demonstrated similar diagnostic efficacy to typical tumour markers (e.g., CEA, Cyfra21‐1, SCC, etc.). Here, SERPINB3 is linked to lung carcinoma.